Prevention of Edema and Flight Microangiopathy with Venoruton ® (HR), (0-[Beta-Hydroxyethyl]Rutosides) in Patients with Varicose Veins

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Angiology

• Publication date

  2005-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/000331970505600308PMID 15889196
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Flight Microangiopathy on Long-Haul Flights: Prevention of Edema and Microcirculation Alterations with Venoruton

  2003cited by this paper
• The LONFLIT4-Venoruton Study

  2003cited by this paper
• The LONFLIT4-VENORUTON Study A Randomized Trial Prophylaxis of Flight-Edema in Normal Subjects

  2003cited by this paper
• Venous Thrombosis from Air Travel: The LONFLIT3 Study

  2002cited by this paper
• Prevention of deep venous thrombosis on long-haul flights

  2002cited by this paper
• Flight Microangiopathy in Medium-to-Long Distance Flights: Prevention of Edema and Microcirculation Alterations with HR (Paroven, Venoruton; 0-(β-hydroxyethyl)-rutosides): A Prospective, Randomized, Controlled Trial

  2002cited by this paper
• Son los fibrinolíticos un tratamiento útil en las reintervenciones de bypass femoropoplíteo

  2001cited by this paper
• The European Unions’ Clinical Trials Directive

  2001cited by this paper
• Venous Thromboembolism from Air Travel

  2001cited by this paper
• Travel and risk of venous thrombosis.

  2001cited by this paper
• Association between acute hypobaric hypoxia and activation of coagulation in human beings.

  2000cited by this paper
• Investigation of chronic venous insufficiency: A consensus statement (France, March 5-9, 1997).

  2000cited by this paper
• Travel and risk of venous thrombosis.

  2000cited by this paper
• The venous clinic

  2000cited by this paper
• Economy-class syndrome presenting as phlegmasia caerulea dolens.

  2000cited by this paper
• Travel as a risk factor for venous thromboembolic disease: a case-control study.

  1999cited by this paper
• Noninvasive Investigations in Vascular Disease

  1998cited by this paper
• Sharing the Final Journey: Walking with the Dying

  1997cited by this paper
• Economy class syndrome: rheology, fluid balance, and lower leg edema during a simulated 12-hour long distance flight.

  1994cited by this paper
• Ambient oxygen tension modulates endothelial fibrinolysis.

  1993cited by this paper
• Acute effects of hydroxyethylrutosides on capillary filtration in normal volunteers, patients with venous hypertension and in patients with diabetic microangiopathy (a dose comparison study).

  1992cited by this paper
• Evaluation of the Microcirculatory Effects of Venoruton (H.R.) in Patients with Chronic Venous Hypertension by Laser-Doppler Flowmetry, Transcutaneous PO2 and PCO2 Measurements, Leg Volumetry and Ambulatory Venous Pressure Measurements

  1989cited by this paper
• Air travel and thrombotic episodes: the economy class syndrome.

  1988cited by this paper
• Sudden Natural Deaths Associated with Commercial Air Travel

  1986cited by this paper
• Medical aspects of transportation aboard commercial aircraft. AMA commission on emergency medical services.

  1982cited by this paper
• Medical aspects of transportation aboard commercial aircraft

  1982cited by this paper
• Pulmonary thromboembolism after travel.

  1977cited by this paper
• Thrombosis of the deep leg veins due to prolonged sitting.

  1954cited by this paper
• SHELTER DEATHS FROM PULMONARY EMBOLISM

  1940cited by this paper

• Management of chronic venous disorders of the lower limbs. Guidelines According to Scientific Evidence. Part I.

  2020cites this paper
• Flavonoids—Quercetin, Citrus Flavonoids, and Hydroxyethylrutosides

  2020cites this paper
• Saururus chinensis (Lour.) Baill blocks enterovirus 71 infection by hijacking MEK1-ERK signaling pathway.

  2015cites this paper
• Teratogenic effect of hydroxyethylrutoside, a flavonoid derivate drug – a population-based case–control study

  2014cites this paper
• Which plant for which skin disease? Part 2: Dermatophytes, chronic venous insufficiency, photoprotection, actinic keratoses, vitiligo, hair loss, cosmetic indications

  2010cites this paper
• Calcium dobesilate and oxerutin: effectiveness of combination therapy

  2010cites this paper
• Prise en charge des affections veineuses chroniques des membres inférieurs: Recommandations basées sur les preuves scientifiques

  2009cites this paper
• Travel-related thromboembolism: mechanisms and avoidance

  2009cites this paper
• Przewleka choroba żylna - patofizjologia, obraz kliniczny i leczenie

  2009cites this paper
• Travel-related thromboembolism:

  2009cites this paper
• Effect of rutin on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats

  2009cites this paper
• Management of chronic venous disorders of the lower limbs: guidelines according to scientific evidence.

  2008cites this paper
• 5-Year Control and Treatment of Edema and Increased Capillary Filtration in Venous Hypertension and Diabetic Microangiopathy Using O-(β-Hydroxyethyl)-Rutosides: A Prospective Comparative Clinical Registry

  2008cites this paper
• Five-year treatment of chronic venous insufficiency with O-(β-hydroxyethyl)-rutosides: safety aspects.

  2008cites this paper
• Traveller's thrombosis: international consensus statement.

  2008cites this paper
• Five-year treatment of chronic venous insufficiency with O-(β-hydroxyethyl)-rutosides: Safety aspects

  2008cites this paper
• Die Bedeutung der medikamentösen Therapie der Varikose

  2008cites this paper
• O-(β-Hydroxyethyl)-Rutosides Systemic and Local Treatment in Chronic Venous Disease and Microangiopathy: An Independent Prospective Comparative Study

  2008cites this paper
• O-(β-Hydroxyethyl)-Rutosides (Paroven; Venoruton): New Studies, Improved Safety, and Novel Cardiovascular Applications

  2008cites this paper
• [Systemic therapy of chronic venous diseases].

  2006cites this paper
• Circulating Endothelial Cells in Venous Blood as a Marker of Endothelial Damage in Chronic Venous Insufficiency: Improvement with Venoruton

  2006cites this paper
• Systemische medikamentöse Therapie von chronischen Venenerkrankungen

  2005cites this paper